S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Could Biden's Executive Order 14017 Trigger A BULL RUN For This Little-Known Industry? (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Could Biden's Executive Order 14017 Trigger A BULL RUN For This Little-Known Industry? (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Could Biden's Executive Order 14017 Trigger A BULL RUN For This Little-Known Industry? (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
YIKES! 220 Pounds of Graphite in Each EV Battery? (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Could Biden's Executive Order 14017 Trigger A BULL RUN For This Little-Known Industry? (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
NASDAQ:PRVA

Privia Health Group - PRVA Stock Forecast, Price & News

$24.17
+0.24 (+1.00%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$24.03
$24.82
50-Day Range
$22.29
$35.91
52-Week Range
$17.99
$44.64
Volume
911,622 shs
Average Volume
1.20 million shs
Market Capitalization
$2.76 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.08

Privia Health Group MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
70.0% Upside
$41.08 Price Target
Short Interest
Healthy
2.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.12mentions of Privia Health Group in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$121.01 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.25) to $0.04 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Medical Sector

212th out of 1,047 stocks

Health Services Industry

3rd out of 12 stocks

PRVA stock logo

About Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.

Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Stock News Headlines

Reviewing Privia Health Group (PRVA) and Its Rivals
China Threat Triggers Potential Mining Boom for Investors
China has almost a 90% lock on critical minerals needed to produce our military, mobile, and green technologies. Mining companies are scrambling to find domestic sources to break China's chokehold on supply chains. Nevada, Idaho and Montana are key to securing a domestic supply.
Privia Health Group (PRVA) versus Its Rivals Critical Contrast
Head to Head Review: Privia Health Group (PRVA) versus Its Rivals
China Threat Triggers Potential Mining Boom for Investors
China has almost a 90% lock on critical minerals needed to produce our military, mobile, and green technologies. Mining companies are scrambling to find domestic sources to break China's chokehold on supply chains. Nevada, Idaho and Montana are key to securing a domestic supply.
Comparing Privia Health Group (PRVA) and Its Peers
Privia Health Group (PRVA) & Its Peers Head to Head Survey
Massive Insider Trade At Privia Health Group
Privia Health Group Insider Trades Send a Signal
Head-To-Head Survey: Privia Health Group (PRVA) & Its Rivals
Privia Health Group (PRVA) & Its Rivals Head-To-Head Review
Analyzing Privia Health Group (PRVA) & Its Peers
Critical Survey: Privia Health Group (PRVA) and The Competition
Privia Health Announces Change to its Board of Directors
Analyst Ratings for Privia Health Group
Privia Health Reports Third Quarter 2022 Financial Results
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Company Calendar

Last Earnings
11/10/2022
Today
12/02/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/28/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
810
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$41.08
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+70.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$-188,230,000.00
Pretax Margin
-3.28%

Debt

Sales & Book Value

Annual Sales
$966.22 million
Book Value
$4.30 per share

Miscellaneous

Free Float
48,463,000
Market Cap
$2.76 billion
Optionable
Not Optionable
Beta
0.67

Key Executives

  • Mr. Matthew Shawn MorrisMr. Matthew Shawn Morris (Age 58)
    CEO & Director
    Comp: $1.46M
  • Mr. Parth MehrotraMr. Parth Mehrotra (Age 43)
    Pres & COO
    Comp: $1.21M
  • Mr. Jeffrey B. Butler (Age 50)
    Founder & Director
    Comp: $46.67k
  • Mr. Thomas BartrumMr. Thomas Bartrum (Age 55)
    Exec. VP & Gen. Counsel
    Comp: $536.6k
  • Mr. David Mountcastle CPAMr. David Mountcastle CPA (Age 51)
    MBA, Exec. VP, CFO & Principal Accounting Officer
  • Mr. Chris Voigt
    Exec. VP & Chief Technology Officer
  • Mr. Robert P. Borchert
    Sr. VP of Investor Relations & Corp. Communications
  • Ms. Dana Fields CPA
    Sr. VP of Internal Audit & Chief Compliance Officer
  • Ms. Jenny Harding
    Sr. VP of People Operations
  • Mr. Jay Stevens
    Sr. VP & Chief Growth Officer













PRVA Stock - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price forecast for 2023?

11 equities research analysts have issued 1-year price targets for Privia Health Group's shares. Their PRVA share price forecasts range from $27.00 to $51.00. On average, they predict the company's share price to reach $41.08 in the next year. This suggests a possible upside of 70.0% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2022?

Privia Health Group's stock was trading at $25.87 on January 1st, 2022. Since then, PRVA shares have decreased by 6.6% and is now trading at $24.17.
View the best growth stocks for 2022 here
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) released its earnings results on Thursday, November, 10th. The company reported $0.01 earnings per share for the quarter. The business earned $342.90 million during the quarter, compared to analysts' expectations of $323.66 million. Privia Health Group had a negative trailing twelve-month return on equity of 6.82% and a negative net margin of 3.02%.

What guidance has Privia Health Group issued on next quarter's earnings?

Privia Health Group issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.30 billion-$1.33 billion, compared to the consensus revenue estimate of $2.25 billion.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an IPO on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

What is Privia Health Group's stock symbol?

Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA."

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (4.22%), Bank of New York Mellon Corp (3.20%), BlackRock Inc. (2.87%), Riverbridge Partners LLC (1.78%), Macquarie Group Ltd. (1.11%) and State Street Corp (0.92%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Privia Health Group's stock price today?

One share of PRVA stock can currently be purchased for approximately $24.17.

How much money does Privia Health Group make?

Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.76 billion and generates $966.22 million in revenue each year. The company earns $-188,230,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis.

How many employees does Privia Health Group have?

The company employs 810 workers across the globe.

How can I contact Privia Health Group?

The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com.

This page (NASDAQ:PRVA) was last updated on 12/2/2022 by MarketBeat.com Staff